Cannabis Law Report

AUGUST 27, 2021

The Board will further serve as a resource for media, other medical associates and general audiences interested in the science behind psychedelic wellness and treatments. Delic is the leading psychedelic wellness platform, committed to bringing science-backed benefits to all and reframing the psychedelic conversation.

Research and Development 98

Research and Development Treatment Media Medicine 98

MMJ Recs

MAY 3, 2024

With its program in full swing, thousands of patients across the state are benefiting from access to this alternative form of treatment. From chronic pain to PTSD, patients with qualifying medical conditions have found solace in medical marijuana where traditional treatments may have fallen short.

Marijuana 52

Marijuana Treatment Compliance Compliance 52

Puff Puff Post

MARCH 2, 2020

Source: New Frontier Data). · Domestic quotas represent a further milestone in the Company’s stated timeline to bring the first medical cannabis products to market in Colombia, targeting patients with two priority conditions; chronic pain and nausea associated with chemotherapy. SOURCE Khiron Life Sciences Corp.

Extraction 52

Extraction THC Chronic Pain Cultivation 52

Cannabis Law Report

DECEMBER 20, 2021

First Patient Expected to be Enrolled by Q2 of 2022. Data To Support Regulatory Filings in the United States. a leading clinical trial services company, for a First in Human study investigating Epoladerm™ for pain associated with osteoarthritis of the knee. Media: Laura Radocaj. BERWYN, Pa.–(BUSINESS

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Data 52

Cannabis Law Report

NOVEMBER 9, 2021

Delic has been focused on opening locations in secondary cities with considerable demand, in an effort to provide access to the most patients. Delic expects to drive considerable patients to KWC through its media platform and build on the existing national leadership position already in place. Transaction Summary.

Treatment 52

Treatment Therapy Media Access 52

Puff Puff Post

MARCH 2, 2020

Source: New Frontier Data). · Domestic quotas represent a further milestone in the Company’s stated timeline to bring the first medical cannabis products to market in Colombia, targeting patients with two priority conditions; chronic pain and nausea associated with chemotherapy. SOURCE Khiron Life Sciences Corp.

Extraction 40

Extraction THC Chronic Pain Cultivation 40

Cannabis Law Report

DECEMBER 14, 2021

The products launched under its flagship medical Ceed brand and are comprised of four formulations that will be available for patients throughout the UK when prescribed by a specialist consultant. Columbia Care’s mission has always been to provide patients with access to the highest quality, safest medicinal cannabis products available.

Extraction 52

Extraction Patients Medicine Tincture 52

Puff Puff Post

SEPTEMBER 16, 2019

16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. “It is our duty as physicians to understand the available treatment options for our patients, and medical cannabis treatments have emerged as an important clinical tool.

Programs 108

Programs Research and Development Education Treatment 108

Cannabis Law Report

NOVEMBER 10, 2021

The NIH has also engaged a firm to manufacture Leu-enkephalin (L-ENK), the active ingredient in Envelta and a firm to manufacture the Molecular Envelope Technology (MET) that is used to carry the L-ENK to the brain to promptly suppress pain. Media: Laura Radocaj. In October 2021, Virpax announced that a $1.87 Christopher M. Betsy Brod.

Research and Development 52

Research and Development Chronic Pain Pharmaceutical Clinical Trials 52

SpeedWeed

APRIL 23, 2021

While the cannabis community was reveling in its celebration of the plant, Talarico turned to social media to share the news of a bill he filed last month. To back up his push for Texas cannabis legalization, he went on to share public opinion data collected by the Texas Tribune in a recent survey, tweeting “this is a popular bipartisan idea.

Legalization 52

Legalization Chronic Pain Policy Legislation 52

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. Background.

Research and Development 52

Research and Development Medicine Access Media 52

Kind Meds (Cannabis Education Blog)

FEBRUARY 24, 2022

was created to perpetuate this stereotype, the federal government had initiated a federal ban, and media portrayal of its so-called ill-effects helped convince many legislators to vote in its favor. Throughout the 20th century, the “stoner” stereotype was often portrayed in the media. Emerald Group Publishing Limited. Moscowitz, L.,

Marijuana 52

Marijuana Research and Development Sleep Strains 52

Cannabis Law Report

JULY 12, 2019

As reported in the Guardian, Analytical Cannabis emphasises the importance of this for those suffering from conditions such as chronic pain, epilepsy and neurological and psychiatric disorders who have long been seeking access to what they hope is a transformative medicine. Background to the legalisation of medical cannabis in the UK.

Epilepsy 40

Epilepsy Medicine Clinical Trials Chronic Pain 40

Puff Puff Post

SEPTEMBER 16, 2019

16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. “It is our duty as physicians to understand the available treatment options for our patients, and medical cannabis treatments have emerged as an important clinical tool.

Programs 40

Programs Research and Development Education Treatment 40

The Cannigma

JANUARY 19, 2022

The resulting prejudice can often discourage folks from seeking out medical cannabis as an option, and can even affect state legislature, forcing patients to overcome unnecessary and prohibitive obstacles in order to receive the treatment they need. Well, partners, of course on the cannabis enigma, yeah, let’s listen to Nikki.

Patients 83

Patients Compliance Compliance Cannabis 83

The Cannigma

APRIL 8, 2021

So yeah, I spend my time helping physicians and nurses more than I do counting bills and talking to patients. Perhaps the patient turns out to be allergic to that medicine or whatnot. What I see is more of a bifurcated model where you have true medical patients. That means you work in a hospital?

Medicine 108

Medicine Cannabinoids Cannabis THC 108

Cannabis Law Report

SEPTEMBER 19, 2019

CBD does not create the same high as THC and can be used for chronic pain and anxiety relief, according to Harvard Medical School. The perplexing narrative of vaping-related lung illnesses escalated into a full-blown national media frenzy last week with news that a fifth person had died from alarming pulmonary symptoms.

Vaping 55

Vaping Hemp Education Patients 55

StrainConnect

APRIL 23, 2019

Most of the Eastern medicine practices combine herbs, spices, and plants to treat their patients. Myrcene is also excellent for reducing inflammation and chronic pain and is a great way to open your receptors to accept cannabinoids. Please email support@strainconnect.com or try us on social media. • 24 Apr, 2019.

Terpenes 63

Terpenes Cannabinoids Therapy Hybrid 63

StrainConnect

FEBRUARY 8, 2019

Now, remember that everyone is different, and new patients will likely still “get high” from products that combine both THC and CBD. Cannabis has been used for therapeutic purposes for thousands of years, and there are no reports of serious adverse effects on patients. Myth #3: You can overdose on cannabinoids. Share by:

Hemp 57

Hemp CBD Cannabinoids Sativa 57